Drupal.behaviors.print = function(context) {window.print();window.close();}>
Roche 454 GS Junior Sales Increase in 2011, While GS FLX Reagent Revenue Drops
February 07, 2012
Roche 454 GS Junior Sales Increase in 2011, While GS FLX Reagent Revenue Drops
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
People in the News: Dan Zabrowski, Thomas Schinecker, Charles Dadswell
April 24, 2013 / Clinical Sequencing News
Study Finds Roche's NGS-Based HIV Assay Comparable to TruGene; Company Expects 2014 CE-IVD Approval
January 30, 2013 / Clinical Sequencing News
IRON-II Study Uses 454 Sequencing to Investigate New Markers for Hematological Malignancies
September 12, 2012 / Clinical Sequencing News
454 Revenues Pick Up in Q3, But Roche's Overall Genomic Sales Decline 12 Percent Year to Date
October 18, 2011 / In Sequence
Paired Ends
July 19, 2011 / In Sequence